Jun 27 2016 Relmada Therapeutics Announces Notice of Allowance for U.S. Patent Covering d-Methadone, an NMDA Receptor Antagonist, for the Treatment of Depression View
Jun 07 2016 Relmada Therapeutics' d-Methadone Receives Orphan Drug Designation for Management of Postherpetic Neuralgia View
May 16 2016 Relmada Therapeutics Announces Promotion of Michael D. Becker to Chief Financial Officer View
May 04 2016 Relmada Therapeutics Announces Results of In Vivo Study Showing d-Methadone has Antidepressant-like Effects View
